Brussels, 28/01/2008 (Agence Europe) - The Stockholm-based European Centre for Disease Prevention and Control says in a press release that the preliminary results of a study on the effectiveness of anti-viral medicines against seasonal flu show that some of the A viruses (H1N1) this winter are resistant to oseltamivir, from the Roche laboratories, which is marketed as Tamiflu. 148 samples of the H1N1 virus isolated in November and December in 10 European countries have been tested by the...